|
|
|
|
| LEADER |
01553nmm a2200337 u 4500 |
| 001 |
EB002144735 |
| 003 |
EBX01000000000000001282861 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230206 ||| eng |
| 100 |
1 |
|
|a Pishko, Allyson
|
| 245 |
0 |
0 |
|a Anticoagulation for venous thromboembolism
|h Elektronische Ressource
|c Allyson Pishko
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2023, 2023
|
| 300 |
|
|
|a 1 streaming video file (18 min.)
|b color, sound
|
| 505 |
0 |
|
|a Contents: Indications for anticoagulation -- Venous thromboembolism (VTE): incidence, treatment, and duration -- "Natural" anticoagulants -- Heparin -- Low molecular weight heparin -- Direct thrombin inhibitors -- Warfarin -- Direct oral anticoagulants -- Provoked VTE -- Unprovoked VTE.
|
| 653 |
|
|
|a Heparin
|
| 653 |
|
|
|a Venous Thromboembolism / drug therapy
|
| 653 |
|
|
|a Anticoagulants (Medicine)
|
| 653 |
|
|
|a Anticoagulants / therapeutic use
|
| 653 |
|
|
|a Thromboembolism / Chemotherapy
|
| 653 |
|
|
|a Venous Thromboembolism / prevention & control
|
| 653 |
|
|
|a Blood Coagulation / drug effects
|
| 653 |
|
|
|a Thromboembolism / Prevention
|
| 653 |
|
|
|a Antithrombins
|
| 653 |
|
|
|a Warfarin
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a The biomedical & life sciences collection
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/5142
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|